Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for J2361. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
16
Median % of Medicare
--
Rate range
$99.47 - $296.40
J2361 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Arkansas | $296.40 | -- | -- | 2026 |
| Arizona | $194.16 | -- | -- | 2026 |
| California | $264.46 | -- | -- | 2026 |
| Illinois | $241.85 | -- | -- | 2026 |
| Kansas | $260.00 | -- | -- | 2026 |
| Michigan | $140.06 | -- | -- | 2026 |
| Minnesota | $99.47 | -- | Required | 2026 |
| Mississippi | $267.80 | -- | -- | 2026 |
| Montana | $267.80 | -- | Required | 2026 |
| Nebraska | $277.68 | -- | -- | 2026 |
| New Hampshire | $260.00 | -- | Not required | 2026 |
| Oklahoma | $260.00 | -- | -- | 2026 |
| South Carolina | $255.84 | -- | -- | 2026 |
| Utah | $260.00* | -- | Required | 2026 |
| Washington | $260.00 | -- | -- | 2026 |
| Wisconsin | $260.00 | -- | -- | 2026 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related drugs codes
- J0013 - Esketamine, nasal spray, 1 mg
- J0120 - Injection, tetracycline, up to 250 mg
- J0121 - Injection, omadacycline, 1 mg
- J0122 - Injection, eravacycline, 1 mg
- J0129 - Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0130 - Injection abciximab, 10 mg
- J0131 - Injection, acetaminophen, not otherwise specified,10 mg
- J0132 - Injection, acetylcysteine, 100 mg
All 157 codes from J2002 to J2998 or every drugs code by number.
Frequently asked questions
How much does Medicaid pay for J2361?
16 state Medicaid programs publish a fee-for-service rate for J2361 (injection, depemokimab-ulaa, 1 mg), ranging from $99.47 in Minnesota to $296.40 in Arkansas. The full table on this page lists every publishing state's current rate.
Which state pays the most for J2361?
Arkansas publishes the highest Medicaid rate for J2361 at $296.40. Minnesota publishes the lowest at $99.47.
Does J2361 require prior authorization under Medicaid?
3 of the 16 publishing states flag J2361 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".